Next Article in Journal
Perspectives on Non-BLT Humanized Mouse Models for Studying HIV Pathogenesis and Therapy
Next Article in Special Issue
Genetic Characterization and Pathogenesis of Avian Influenza Virus H7N3 Isolated from Spot-Billed Ducks in South Korea, Early 2019
Previous Article in Journal
N-Linked Glycosylation on Anthrax Toxin Receptor 1 Is Essential for Seneca Valley Virus Infection
Previous Article in Special Issue
Within-Host and Between-Host Evolution in SARS-CoV-2—New Variant’s Source
Brief Report

Global Discrepancies between Numbers of Available SARS-CoV-2 Genomes and Human Development Indexes at Country Scales

by 1,2 and 1,2,*
1
IHU Méditerranée Infection, 19–21 Boulevard Jean Moulin, 13005 Marseille, France
2
Aix-Marseille University, Institut de Recherche pour le Développement (IRD), Assistance Publique-Hôpitaux de Marseille (AP-HM), MEPHI, 27 Boulevard Jean Moulin, 13005 Marseille, France
*
Author to whom correspondence should be addressed.
Academic Editors: Maite F.S. Vaslin, Fabrício S. Campos and Luciana Barros de Arruda
Viruses 2021, 13(5), 775; https://doi.org/10.3390/v13050775
Received: 8 March 2021 / Revised: 22 April 2021 / Accepted: 26 April 2021 / Published: 28 April 2021
It has now been over a year since SARS-CoV-2 first emerged in China, in December 2019, and it has spread rapidly around the world. Some variants are currently considered of great concern. We aimed to analyze the numbers of SARS-CoV-2 genome sequences obtained in different countries worldwide until January 2021. On 28 January 2021, we downloaded the deposited genome sequence origin from the GISAID database, and from the “Our world in data” website we downloaded numbers of SARS-CoV-2-diagnosed cases, numbers of SARS-CoV-2-associated deaths, population size, life expectancy, gross domestic product (GDP) per capita, and human development index per country. Files were merged and data were analyzed using Microsoft Excel software. A total of 450,968 SARS-CoV-2 genomes originating from 135 countries on the 5 continents were available. When considering the 19 countries for which the number of genomes per 100 deaths was >100, six were in Europe, while eight were in Asia, three were in Oceania and two were in Africa. Six (30%) of these countries are beyond rank 75, regarding the human development index and four (20%) are beyond rank 80 regarding GDP per capita. Moreover, the comparisons of the number of genomes sequenced per 100 deaths to the human development index by country show that some Western European countries have released similar or lower numbers of genomes than many African or Asian countries with a lower human development index. Previous data highlight great discrepancies between the numbers of available SARS-CoV-2 genomes per 100 cases and deaths and the ranking of countries regarding wealth and development. View Full-Text
Keywords: SARS-CoV-2; genome; next-generation sequencing; country-scale development; world; variant SARS-CoV-2; genome; next-generation sequencing; country-scale development; world; variant
Show Figures

Figure 1

MDPI and ACS Style

Colson, P.; Raoult, D. Global Discrepancies between Numbers of Available SARS-CoV-2 Genomes and Human Development Indexes at Country Scales. Viruses 2021, 13, 775. https://doi.org/10.3390/v13050775

AMA Style

Colson P, Raoult D. Global Discrepancies between Numbers of Available SARS-CoV-2 Genomes and Human Development Indexes at Country Scales. Viruses. 2021; 13(5):775. https://doi.org/10.3390/v13050775

Chicago/Turabian Style

Colson, Philippe, and Didier Raoult. 2021. "Global Discrepancies between Numbers of Available SARS-CoV-2 Genomes and Human Development Indexes at Country Scales" Viruses 13, no. 5: 775. https://doi.org/10.3390/v13050775

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop